FFA
GILD icon

Frazier Financial Advisors’s Gilead Sciences GILD Stock Holding History

Frazier Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562 Sell
4
-28
-88% -$3.92K ﹤0.01% 693
2025
Q4 		$3.93K Buy
32
+31
+3,100% +$3.77K ﹤0.01% 496
2025
Q3 		$137 Sell
1
-11
-92% -$1.25K ﹤0.01% 622
2025
Q2 		$1.34K Hold
12
– – ﹤0.01% 531
2025
Q1 		$1.34K Sell
12
-11
-48% -$1.14K ﹤0.01% 511
2024
Q4 		$2.1K Hold
23
– – ﹤0.01% 507
2024
Q3 		$1.9K Sell
23
-35
-60% -$2.67K ﹤0.01% 714
2024
Q2 		$4.01K Buy
58
+32
+123% +$2.14K ﹤0.01% 670
2024
Q1 		$1.92K Sell
26
-82
-76% -$6.31K ﹤0.01% 748
2023
Q4 		$8.74K Buy
+108
New +$8.4K 0.01% 378

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Frazier Financial Advisors's GILD Position: Q1 2026 in Review

Frazier Financial Advisors reduced its Gilead Sciences (GILD) stake by 88% in Q1 2026, selling an estimated $3.92K and leaving 4 shares worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Frazier Financial Advisors first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.74K in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Frazier Financial Advisors held 4 shares of Gilead Sciences worth $562 as of Q1 2026.
  • Frazier Financial Advisors sold 28 Gilead Sciences shares in Q1 2026, an estimated $3.92K.
  • Gilead Sciences made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #693 holding.
  • Frazier Financial Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Gilead Sciences position peaked at $8.74K in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.